Even though sunitinib is a known treatment strategy for wild-type GIST, this is a unique case since most GISTs with wild type KIT do not respond to tyrosine kinase inhibitor (TKI) treatment26. This evidence concerns the gene KIT and gastrointestinal stromal tumor.